Report
EUR 13.91 For Business Accounts Only

Increased risk weighs on SOULBRAIN HOLDINGS CTD., penalising its rating down to Slightly Negative

The independent financial analyst theScreener just lowered the general evaluation of SOULBRAIN HOLDINGS CTD. (KR), active in the Speciality Chemicals industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date May 21, 2021, the closing price was KRW 38,050.00 and its target price was estimated at KRW 33,210.07.
Underlying
Soulbrain Holdings

Soulbrain Co. is engaged in the manufacture of chemical products such as HF, MAE, TEOS/DOPANTS, HP/BHF and gas supply. Co. also provides chrome-etchants for thin film transistor-liquid crystal displays and ceric ammonium nitrates, lithium battery electrolytes, optical fibers and neodymium magnets.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch